Stability and analysis of 2-chloro-2'-deoxyadenosine, 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine and 2-chloroadenine in human blood plasma

被引:4
作者
Lindemalm, S
Albertioni, F
Liliemark, J
机构
[1] KAROLINSKA HOSP,DEPT CLIN PHARMACOL,S-17176 STOCKHOLM,SWEDEN
[2] KAROLINSKA HOSP,DEPT ONCOL,S-17176 STOCKHOLM,SWEDEN
关键词
2-chloro-2'-arabino-fluoro-2'-deoxy-adenosine; 2-chloro-2'-deoxyadenosine; chloroadenosine; reverse-phase HPLC; stability; storage;
D O I
10.1097/00001813-199706000-00005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cladribine (2-chloro-2'-deoxyadenosine, CdA) is a purine nucleoside analog with activity against lymphoproliferative and autoimmune disorders. 2-Chloro-2'-arabino-fluoro-2'-deoxyadenosine (CAFdA), a derivative of CdA with better acid stability, shows a similar in vitro spectrum of activity as CdA. 5-Chloroadenine (CAde) is the major catabolite of both CdA and CAFdA. We have developed a high performance liquid chromatography method to measure CdA, CAFdA and their metabolite CAde in plasma. This method employees an internal standard, chloroadenosine (CAdo), and a C-8 solid-phase extraction to isolate and concentrate the substances. Chromatographic separation was achieved using a C-8 reverse-phase column, with UV detection at 265 nm, which gives a limit of detection of 1 nmol/l for all substances. The method was reproducible with intra- and inter-assay coefficients of variations below 6% at 50 nmol/l and at 5 nmol/l below 23%. The average recoveries of CdA, CAde, CAFdA and the internal standard were higher than 70%. Stability studies of authentic patient samples show that samples containing CdA should be kept in a refrigerator or on ice to prevent degradation. plasma containing CAde should not be kept at -20 degrees C for longer than 10 weeks before analysis. CdA and CAFdA remain almost stable during storage at -20 degrees C for 12 weeks.
引用
收藏
页码:445 / 453
页数:9
相关论文
共 17 条
[1]   ON THE BIOAVAILABILITY OF 2-CHLORO-2'-DEOXYADENOSINE (CDA) - THE INFLUENCE OF FOOD AND OMEPRAZOLE [J].
ALBERTIONI, F ;
JULIUSSON, G ;
LILIEMARK, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (06) :579-582
[2]   ANALYSIS OF 2-CHLORO-2'-DEOXYADENOSINE IN HUMAN BLOOD-PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY USING SOLID-PHASE EXTRACTION [J].
ALBERTIONI, F ;
PETTERSSON, B ;
REICHELOVA, V ;
JULIUSSON, G ;
LILIEMARK, J .
THERAPEUTIC DRUG MONITORING, 1994, 16 (04) :413-418
[3]   CLADRIBINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL IN HEMATOLOGICAL MALIGNANCIES [J].
BRYSON, HM ;
SORKIN, EM .
DRUGS, 1993, 46 (05) :872-894
[4]   ORAL ANTILYMPHOCYTE ACTIVITY AND INDUCTION OF APOPTOSIS BY 2-CHLORO-2'-ARABINO-FLUORO-2'-DEOXYADENOSINE [J].
CARSON, DA ;
WASSON, DB ;
ESPARZA, LM ;
CARRERA, CJ ;
KIPPS, TJ ;
COTTAM, HB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (07) :2970-2974
[5]  
CARSON DA, 1983, BLOOD, V62, P737
[6]   SYNTHESIS AND BIOLOGICAL-ACTIVITY OF SELECTED 2,6-DISUBSTITUTED-(2-DEOXY-ALPHA-D-ERYTHRO-PENTOFURANOSYL) AND -BETA-D-ERYTHRO-PENTOFURANOSYL)PURINES [J].
CHRISTENSEN, LF ;
BROOM, AD .
JOURNAL OF MEDICINAL CHEMISTRY, 1972, 15 (07) :735-+
[7]   DISTRIBUTION OF PENTOBARBITAL AND DIPHENYLHYDANTOIN BETWEEN PLASMA AND CELLS IN BLOOD - EFFECT OF SALICYLIC-ACID, TEMPERATURE AND TOTAL DRUG CONCENTRATION [J].
EHRNEBO, M ;
ODARCEDERLOF, I .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 11 (01) :37-42
[8]  
GAJEWSKA M, 1995, PHARMAZIE, V50, P459
[9]   SUBCUTANEOUS INJECTIONS OF 2-CHLORODEOXYADENOSINE FOR SYMPTOMATIC HAIRY-CELL LEUKEMIA [J].
JULIUSSON, G ;
HELDAL, D ;
HIPPE, E ;
HEDENUS, M ;
MALM, C ;
WALLMAN, K ;
STOLT, CM ;
EVENSEN, SA ;
ALBERTIONI, F ;
TJONNFJORD, G ;
LENKEI, R ;
LILIEMARK, J .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (04) :989-995
[10]   ON THE BIOAVAILABILITY OF ORAL AND SUBCUTANEOUS 2-CHLORO-2'-DEOXYADENOSINE IN HUMANS - ALTERNATIVE ROUTES OF ADMINISTRATION [J].
LILIEMARK, J ;
ALBERTIONI, F ;
HASSAN, M ;
JULIUSSON, G .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (10) :1514-1518